HUTCHMED (China) Ltd
20-F
March 5, 2026
Key Highlights
- HUTCHMED achieved a robust 25% increase in total revenue, reaching $550 million,...
- The U.S. FDA approved SULANDA (fruquintinib) for metastatic colorectal cancer, m...
- The company maintains a strong financial position with $780 million in cash and ...
Read Analysis
🤖 AI Generated